Michael WEICHEL

Person

Bischofsheim, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Multivalent FV antibodies
- Patent number 11,572,415
- Issue date Feb 7, 2023
- Affimed GMBH
- Kristina Ellwanger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tandem diabody for CD16A-directed NK-cell engagement
- Patent number 11,180,558
- Issue date Nov 23, 2021
- Affimed GMBH
- Thorsten Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 10,626,190
- Issue date Apr 21, 2020
- Amphivena Therapeutics, Inc.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD3 binding domains
- Patent number 10,066,015
- Issue date Sep 4, 2018
- Affirmed GmbH
- Eugene Zhukovsky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 9,803,029
- Issue date Oct 31, 2017
- AMPHIVENA THERAPEUTICS, INC.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 9,212,225
- Issue date Dec 15, 2015
- AMPHIVENA THERAPEUTICS, INC.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD FOR THE PRODUCTION OF BISPECIFIC FCYRIII X CD30 ANTIBODY CON...
- Publication number 20220340674
- Publication date Oct 27, 2022
- Affimed GmbH
- Claudia WALL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tandem Diabody for CD16A-directed NK-cell Engagement
- Publication number 20220041717
- Publication date Feb 10, 2022
- Affimed GmbH
- Thorsten ROSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20210024654
- Publication date Jan 28, 2021
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tandem Diabody for CD16A-directed NK-cell Engagement
- Publication number 20190345249
- Publication date Nov 14, 2019
- Thorsten Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIVALENT FV ANTIBODIES
- Publication number 20190040155
- Publication date Feb 7, 2019
- Affimed GmbH
- Kristina ELLWANGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20180291113
- Publication date Oct 11, 2018
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE
- Publication number 20170037128
- Publication date Feb 9, 2017
- Affimed GmbH
- Melvyn LITTLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20160194409
- Publication date Jul 7, 2016
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD3 BINDING DOMAINS
- Publication number 20160039934
- Publication date Feb 11, 2016
- Affimed GmbH
- Eugene ZHUKOVSKY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20160002333
- Publication date Jan 7, 2016
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Michael WEICHEL

Person

Patents Grantslast 30 patents

Multivalent FV antibodies

Tandem diabody for CD16A-directed NK-cell engagement

Bispecific CD33 and CD3 binding proteins

CD3 binding domains

Bispecific CD33 and CD3 binding proteins

Bispecific CD33 and CD3 binding proteins

Patents Applicationslast 30 patents

METHOD FOR THE PRODUCTION OF BISPECIFIC FCYRIII X CD30 ANTIBODY CON...

Tandem Diabody for CD16A-directed NK-cell Engagement

Bispecific CD33 and CD3 Binding Proteins

Tandem Diabody for CD16A-directed NK-cell Engagement

MULTIVALENT FV ANTIBODIES

Bispecific CD33 and CD3 Binding Proteins

TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE

Bispecific CD33 and CD3 Binding Proteins

CD3 BINDING DOMAINS

Bispecific CD33 and CD3 Binding Proteins